Bacterial and mammalian F

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• F1FO-ATPase is a ubiquitous enzyme complex vital for energy transduction in mitochondria, chloroplasts, and bacteria.
• This enzyme complex facilitates ATP synthesis and hydrolysis through a conserved molecular mechanism.
• Structural differences exist between prokaryotic and eukaryotic F1FO-ATPases, presenting opportunities for targeted drug design.

Purpose of the Study:

• To explore the potential of targeting bacterial F1FO-ATPase for antimicrobial drug development.
• To investigate the specific structural features of prokaryotic ATP synthases that can be exploited as drug targets.
• To highlight the role of the c-ring subunit in selective inhibition of mycobacterial F1FO-ATPase.

Main Methods:

• Comparative analysis of structural divergences between bacterial and mammalian F1FO-ATPases.
• Identification of the c-ring as a key target for selective inhibition.
• Evaluation of diarylquinoline compounds, specifically bedaquiline, for their ability to inhibit mycobacterial F1FO-ATPase.

Main Results:

• The bacterial F1FO-ATPase's c-ring subunit exhibits unique structural characteristics compared to its mammalian counterpart.
• Diarylquinolines, exemplified by bedaquiline, demonstrate selective inhibition of mycobacterial F1FO-ATPase by targeting the c-ring.
• This targeted inhibition occurs without affecting homologous enzymes in mammals.

Conclusions:

• The unique structure of the bacterial F1FO-ATPase c-ring serves as a viable target for novel antimicrobial agents.
• Bedaquiline's specific interaction with the mycobacterial c-ring offers a molecular basis for treating infections caused by antibiotic-resistant bacteria.
• Targeting conserved yet distinct enzyme structures provides a promising strategy in the fight against antimicrobial resistance.